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BACKGROUND: Hyperglycemia in diabetic patients cause both chronic inflammation and extracellular matrix accumulation that can 
lead to progressive renal damage. Albumin, Gamma-
glutamytransferase (GGT) and clusterin in urine are 
markers to detect damage in glomerulus, cell of the tubules 
and  proximal tubules, respectively.
METHODS: This study aimed to evaluate the 
pathomechanism of haemoglobin A1c (HbA1c), albumin, 
GGT, clusterin, type IV collagen in urine, and high-
sensitivity C-reactive protein (hsCRP) in type 2 diabetes 
mellitus (DM) patients. The study was a cross sectional 
study involving 82 subjects consisting of 36 males and 46 
females, 35-65 years old, divided into 3 groups: uncontrolled 
DM, controlled DM and non DM. Data were obtained from 
interviews, physical examinations (weight, height, blood 
pressure) and laboratory examinations ((HbA1c, serum 
glutamic oxaloacetic (SGOT), serum glutamic pyruvic 
(SGPT), creatinine,  hsCRP, urinary albumin, urinary GGT, 
urinary clusterin, and urinary type IV collagen). Statistical 
analysis was performed for correlation, difference and cross 
tabulation tests.
RESULTS: The study results showed there were significant 
differences (p<0.05) between uncontrolled DM group 
compared with controlled DM and non DM groups in 
HbA1c, ratio of urinary type IV collagen and ratio of 
urinary albumin. However, there were no significant 
differences between controlled DM and non DM groups. 
There were positive significant correlations between HbA1c 
with hsCRP (r=0.223, p<0.05), HbA1c with ratio of urinary 
type IV collagen/creatinine (r=0.563, p<0.001), HbA1c 
with ratio of urinary albumin/creatinine (r=0.263, p<0.05), 
and ratio of urinary type IV collagen/creatinine with ratio 
urinary albumin/creatinine (r=0.613, p<0.001).
LATAR BELAKANG: Hiperglikemia pada pasien diabetes menyebabkan inflamasi kronis dan akumulasi matriks ekstraselular yang dapat 
berlanjut menjadi kerusakan ginjal. Albumin, Gamma-
glutamytransferase (GGT) and clusterin pada urin 
merupakan penanda untuk mendeteksi kerusakan pada 
glomerulus, sel tubulus dan tubulus proksimal.
METODE: Penelitian ini bertujuan untuk mengevaluasi 
patomekanisme hemoglobin A1c (HbA1c), albumin, 
GGT, clusterin, kolagen tipe IV urin, dan high-sensitivity 
C-reactive protein (hsCRP) pada pasien diabetes melitus 
(DM) tipe 2. Penelitian ini merupakan studi cross sectional 
dengan melibatkan 82 subyek yang terdiri dari 36 laki-
laki dan 46 perempuan, usia 35-65 tahun, yang kemudian 
dibagi menjadi 3 grup: DM tidak terkontrol, DM terkontrol 
dan non DM. Data didapatkan dari hasil wawancara, 
pemeriksaan fisik (berat badan, tinggi badan, tekanan darah) 
dan pemeriksaan laboratorium (HbA1C, serum glutamic 
oxaloacetic (SGOT), serum glutamic pyruvic (SGPT), 
kreatinin, hsCRP, albumin urin, GGT urin, clusterin urin, 
dan kolagen tipe IV urin). Analisa statistik dilakukan untuk 
tes korelasi, perbedaaan dan tabulasi silang.
 
HASIL: Hasil penelitian memperlihatkan perbedaan 
bermakna (p<0,05) antara grup DM tidak terkontrol dengan 
grup DM terkontrol dan non DM pada pemeriksaan HbA1c, 
rasio kolagen tipe IV urin and rasio albumin urin. Akan 
tetapi, tidak ada perbedaan bermakna antara grup DM 
terkontrol dan non DM. Terdapat korelasi positif yang 
bermakna antara HbA1c dengan hsCRP (r=0,223, p<0,05), 
HbA1c dengan rasio kolagen tipe IV urin/kreatinin (r=0,563, 
p<0,001), HbA1c dengan rasio albumin urin/kreatinin 
(r=0,263, p<0,05), dan rasio kolagen tipe IV urin/kreatinin 
dengan rasio albumin urin/kreatinin (r=0,613, p<0,001).
Abstract Abstrak
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CONCLUSION: Results of this study indicated that 
albumin and type IV collagen in urine play a role in renal 
damage caused by uncontrolled glucose level in subjects 
with type 2 DM. The increased concentration of both 
HbA1c and urinary type IV collagen indicates increased 
risk factor of glomerulus damage. Urinary type IV collagen 
is  likely to be future potential marker for early detection of 
renal damage.
KEYWORDS: renal damage, HbA1c, hsCRP, type IV 
collagen, GGT, clusterin, diabetes mellitus
Indones Biomed J. 2013; 5(3): 161-8
KESIMPULAN: Hasil penelitian mengindikasikan bahwa 
albumin dan kolagen tipe IV urin berperan dalam kerusakan 
ginjal yang disebabkan oleh level glukosa tidak terkontrol 
pada subyek DM tipe 2. Peningkatan konsentrasi HbA1c 
dan kolagen tipe IV urin mengindikasikan peningkatan 
faktor risiko kerusakan glomerulus. Kolagen tipe IV urin 
berpotensi menjadi penanda untuk deteksi awal kerusakan 
ginjal.
KATA KUNCI: kerusakan ginjal, HbA1c, hsCRP, kolagen 
tipe IV, GGT, clusterin, diabetes melitus
Introduction
Diabetes mellitus (DM) is characterized by hyperglycemia 
caused by insulin deficiency and/or insulin resistance.(1) 
According to the American Diabetes Association in 2010, 
DM is a group of metabolic diseases with characteristic 
hyperglycaemia that occurs due to disorder of insulin 
secretion, insulin action or both.(2)
 Several epidemiological studies have shown a trend 
of increase in the incidence and prevalence of type 2 DM in 
many parts of the world. World Health Organization (WHO) 
has predicted the number of DM patients will  sharply 
increase in the future. WHO and International Diabetes 
Federation (IDF) have predicted an increase in the number 
of people with type 2 DM at 2-3 fold in 2030.(2)
 DM can lead to microvascular and macrovascular 
complications as a result of exposure to chronic 
hyperglycemia.(1,3) Among the microvascular 
complications, diabetic kidney disease is one of the most 
serious with a significant impact on morbidity, mortalitiy 
and quality of life of the sufferers. About 20-40% of people 
with DM will progress to diabetic nephropathy (DN)(2), 
which  is a leading cause of end-stage renal disease (ESRD)
(4). Deaths due to kidney disease are 17 times more frequent 
in diabetic patients than in non-diabetic patients.(5)
 Clinical studies have demonstrated that high blood 
glucose is always the main cause of the initiation and 
progression of diabetic vascular complications including 
nephropathy. Hiperglycemia induces reactive oxygen species 
(ROS) formation, activates signal tranduction cascade 
and transcription factor-induced ROS, over-expression 
of genes and proteins in the glomerular mesangium, and 
tubular epithelial cells may result in the accumulation of 
extracellular matrix (ECM) in diabetic kidney.(6)
 A number of clinical and animal studies on 
inflammatory mechanisms as an important pathogenic factor 
in diabetic complications including glomerulosclerosis have 
indicated there was some evidences of the inflammatory role 
in the progression of tubulointerstital injury in DN. Increase 
in the circulation of a number of inflammatory markers such 
as C-reactive protein (CRP), fibrinogen, serum amyloid 
A protein (SAA), and Interleukin-6 (IL-6) correlated with 
albuminuria and deposition of ECM proteins in patients with 
both type 1 and type 2 DM, and as such causing increased 
risk of renal disease progression.(7)
 Early renal tubular damage is characterized by 
increased enzimuria of proximal tubulus such as β-N-
acetyl-glycosaminidase (β-NAG), gamma glutamyl 
transferase (GGT), lactate dehydrogenase (LDH) and 
alkaline phosphatase (ALP). Increased urinary enzyme 
can be used to detect nephrotoxicity and renal disease.(8) 
The presence of specific enzymes in urine is due to cellular 
damage caused by cell lysis, necrosis or loss of the luminal 
membrane of drug-induced.(9)
 Clusterin is a glycoprotein involved in many 
physiological and patho-physiological processes that 
consists of two types, namely the exogenous secretory type 
contained in biological fluids, and the endogenous secretory 
type contained in the cytoplasm and nucleus.(10) Clusterin 
in renal excretion is prominently found only in the early 
stages of nephron development, but will then reappear with 
the various types of acute and chronic injury.(11) Clusterin 
was identified as a biomarker for kidney injury, especially 
in the tubular system, because it will be up-regulated in the 
renal tissue immediately after exposure to toxin.(9)
 Studies with animal trials and on the genetic aspects 
of DM have reported that ECM expansion in the glomerulus 
exceeds glomerular filtration associated with excessive 
production of type IV collagen. Type IV collagen is a major 
component of the glomerular basement membrane and 
mesangial matrix. A small amount of type IV collagen is 
excreted into the urine in healthy subjects.(12,13)
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Subjects
Study population were subjects aged 35-65 years with 
no smoking habit, no alcoholic habit, no heart disease 
history, no malignancy disease, no anti-inflammatory 
drugs consumption, with/without type 2 DM.  Subjects 
with hypertension, glomerular flow rate <60 mL/minute/ 
1.73 m2 (counting with formula of chronic kidney disease 
epidemiology collaboration), high-sensitivity C-reactive 
protein (hs-CRP) ≥10, serum glutamic oxaloacetic (SGOT) 
and/or serum glutamic pyruvic (SGPT) >2 fold the upper 
normal limit, were excluded from the study. The study 
protocol was approved by the Health Research Ethics 
Committee, Faculty of Medicine, Hasanuddin University, 
Makassar (No. UH13030104). All participants were notified 
about the objectives of study and an informed consent was 
obtained from each study subjects.
Specimen Collection and Biochemical Analysis 
Blood specimens and second morning urine were collected 
after an overnight fasting for 10-12 hours. Measurement of 
anthropometric parameters (waist circumference, height, 
weight) and blood pressure were carried out. Biochemical 
variables were done according to in kit insert as follows: 
concentration of SGOT (Cat. No.: 20764949322, Roche 
Diagnostics GmbH, Mannheim, Germany), SGPT (Cat. No.: 
Methods
General characteristics of subjects
A total of 82 subjects were analyzed, consisting of 65 subjects 
with DM and 20 subjects with non DM. Subjects with DM 
with HbA1c levels ≥7% were categorized as uncontrolled 
DM and those with HbA1c <7% were categorized as 
controlled DM. DM duration of subjects was between 0.5-
38 years (median=3 years). Characteristics of study subjects 
and the results of normality test data are shown in Table 1.
Results
20764957322, Roche Diagnostics GmbH), urea N (Cat. No.: 
4460715190, Roche Diagnostics GmbH), serum creatinine 
(Cat. No.: 3263991190, Roche Diagnostics GmbH), urinary 
creatinine (Cat. No.: 04992596, Roche Diagnostics GmbH), 
hs-CRP (Cat. No.: 4628918190, Roche Diagnostics GmbH), 
urinary albumin (Cat. No.: 03051194, Roche Diagnostics 
GmbH) and HbA1c (Cat. No.: 2200112, Biorad, Richmond, 
CA). Whereas urinary type IV collagen (Cat. No.: BIO83, 
Argutus Medical, Dublin, Ireland) and urinary clusterin 
(Cat. No.: DCLU00, R&D systems, Inc., Minneapolis, MN) 
were measured by enzyme immunoassay methods.
Statistical analysis 
 Statistical analysis were performed with SPSS 
for Windows version 16.0 (SPSS Inc., Chicago, IL). 
Distributions of continuous variables were assessed for 
normality using Kolmogorov-Smirnov test. Correlation 
between variables was analyzed using Pearson and Spearman 
correlation analysis. Independent sample T test was done for 
comparison between groups.  For the statistical test we used 
5% to define the level of significance. Crosstabs analysis 
was done to assess the risk factor of parameters  increase 
due to increased levels of HbA1c.
 Based on this background, this study was conducted to 
assess the relationship between Haemoglobin A1c (HbA1C) 
with hs-CRP and urinary biomarkers (GGT, albumin, 
clusterin, type IV collagen) in subjects with type 2 DM 
and to elucidate the pathomechanism of the renal damage 
involved.
Variable Min Max Mean ± SD Median p*
          Age (year) 35.00 65 51.11 ± 9.09 - 0.461
          BMI (Kg/m2) 16.79 39.01 25.57 ± 3.59 - 0.968
HbA1c (%) 4.3 16 - 7.1 0.046
hs-CRP (mg/dL) 0.160 8.801 - 1.338 0.003
Urinary Albuin/creatinine (μg/mg) 3 550 - 11 0.000
Urinary Clusterin (ng/mL) 5.50 1,245.60 - 142.98 0.020
Urinary Type IV Collagen/Creatinine (μg/g) 0.500 29 - 2.754 0.002
Duration of DM (year) 0.5 38 - 3 0.006
Table 1. General characteristics of  subjects and normality test (n=82).
*: distribution assessment with Kolmogorov Smirnov test; BMI: body mass index.
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Table 2. Comparison of biomarkers among groups.
Uncontrolled DM
(n=42)
Controlled DM
(n=20)
Non DM
(n=20)
Mean ± SD / Median Mean ± SD / Median Mean ± SD / Median
Age (year) 52.40 ± 9.01 50.10 ± 9.78 49.80 ± 8.72 0.532
BMI (Kg/m2) 25.58 ± 3.38 24.89 ± 3.52 26.24 ± 4.14 0.838
HbA1c (%) 9.4 5.7 5.5 0.000
hs-CRP (mg/dL) 1.482 1.511 1.237 0.260
Urinary Albumin/Creatinine (μg/mg) 18.5 4 7 0.007
Urinary Clusterin (ng/mL) 142.02 137.05 162.38 0.819
Urinary Type IV Collagen/Creatinine (μg/g) 4.23 1.85 2.12 0.002
Duration of DM (year) 3 2.9 - 0.001
Variable p*
*: Independent t test between Unctrolled and Controlled DM groups.
hs-CRP 
(mg/dL)
Urinary 
Type IV Collagen/Creatinine
(μg/mg)
Urinary GGT
(U/L)
Urinary 
Albumin/Creatinine
(μg/mg)
Urinary 
Clusterin
(ng/mL) 
HbA1c (%) r 0.223* 0.513** -0.189 0.263* -0.164
p 0.045 0.000 0.093 0.019 0.146
hs-CRP (mg/dL) r 1.000 0.173 -0.029 0.180 -0.008
p - 0.120 0.797 0.105 0.945
Urinary Type IV Collagen/Creatinine r 0.173 1.000 -0.128 0.613** 0.143
p 0.120 - 0.253 0.000 0.200
HbA1c r 0.370* 0.380 0.314* -0.100 -0.112
p 0.017 0.014 0.049 0.538 0.492
hs-CRP r 1.000 0.104 0.321 -0.162 0.110
p - 0.514 0.040 0.310 0.947
Urinary Type IV Collagen/Creatinine r 0.104 1.000 0.560** -0.049 0.142
p 0.514 - 0.000 0.762 0.374
HbA1c r -0.173 -0.133 -.0.156 0.135 -0.067
p 0.479 0.588 0.536 0.593 0.792
hs-CRP r 1.000 0.032 0.754 0.393 0.057
p - 0.892 0.077 0.096 0.817
Urinary Type IV Collagen/Creatinine r 0.032 1.000 0.269 -0.165 -0.044
p 0.892 - 0.251 0.488 0.855
HbA1c r 0.306 0.145 -0.055 -0.294 -0.195
p 0.190 0.541 0.830 0.237 0.437
hs-CRP r 1.000 0.289 0.237 -0.128 0.035
p - 0.217 0.313 0.591 0.885
Urinary Type IV Collagen/Creatinine r 0.289 1.000 0.435 0.098 0.456*
p 0.217 - 0.055 0.682 0.043
Non DM (n=20)
Controlled DM (n=20)
Total Population (n=82)
Uncontrolled DM (n=42)
*
*
Table 3. Correlation analyses between biomarkers.
Pearson and Spearman correlation analysis. *: p<0.05; **: p<0.001
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Comparison of Biomarkers among Groups
Median value of urinary collagen type IV/creatinine ratio 
was found higher in uncontrolled DM group compared with 
controlled DM and non DM groups (4.23, 1.85 and 2.12 
µg/mg, respectively). There was a significant difference 
(p<0.05) between uncontrolled DM and controlled DM 
groups, but no significant difference was noted between 
controlled and non DM groups. Median value of urinary 
albumin/creatinine ratio was found higher in uncontrolled 
DM group compared with controlled DM and non DM 
groups (18.50, 4 and 7 µg/mg, respectively).  There was a 
significant difference (p<0.05) seen between uncontrolled 
DM and controlled DM groups, but no significance 
difference (p>0.05) between controlled DM and non DM 
groups. 
Correlation analyses between Biomarkers (HbA1c, hs-
CRP, Urinary Type IV Collagen, Albumin, GGT and 
Clusterin)
There was a significant correlation (p<0.05) between 
HbA1c and hs-CRP, as shown in Table 3. Significant 
positive correlation (r=0.223, p<0.05) was shown in total 
population and uncontrolled DM group (r=0.370, p<0.05). 
There was a significant positive correlation between 
≥30 <30
N 19 23 42 0 7.435
% HbA1c 45.20% 54.80% 100.00%
% Urinary albumin 82.60% 39.00% 51.20%
% Total 23.20% 28.00% 51.20%
N 4 36 40
% HbA1c 10.00% 90.00% 100.00%
% Urinary albumin 17.40% 61.00% 48.80%
% Total 4.90% 43.90% 48.80%
N 23 59 82
% HbA1c 28.00% 72.00% 100.00%
% Urinary albumin 100.00% 100.00% 100.00%
% Total 28.00% 72.00% 100.00%
Urinary Albumin
Total p OR
     Total
     HbA1c ≥7
     HbA1c <7
Table 4. Crosstabs analysis between HbA1c and urinary albumin.
OR: odds ratio
HbA1c and urinary type IV collagen/creatinine ratio as a 
marker of extracellular matrix (ECM) accumulation in total 
population (r=0.513, p<0.001) and uncontrolled DM group 
(r=0.380, p<0.05) (Table 3). There was a positive significant 
correlation between HbA1c and urinary albumin/creatinine 
ratio in total population (r=0.263, p<0.05). Also we found 
significant positive correlation between urinary type IV 
collagen/creatinine ratio and urinary albumin/creatinine 
ratio (r=0.613, p<0.001). In uncontrolled DM group, 
HbA1c, hs-CRP and urinary type IV collagen/creatinine 
ratio were all positive significantly correlated with urinary 
GGT (r=0.314, p<0.05; r=0.321, p<0.05; r=0.560, p<0.001, 
respectively).There was a positive significant correlation 
between urinary type IV collagen/creatinine ratio and 
urinary clusterin in non DM (r=0.456, p<0.05). There 
was no significant correlation found between hs-CRP and 
urinary type IV collagen/creatinine ratio.
4.2 (n=21) <4.2 (n=21) 4.2 (n=2) <4.2 (n=18) 4.2 (n=1) <4.2 (n=19)
  30 11 (52.4%) 8 (38.1%) 1 (50%) 2 (11.1%) 0 (0%) 1 (5.3%)
<30 10 (47.6%) 13 (61.9%) 1 (50%) 16 (88.9%) 1 (100%) 18 (94.7%)
   Urinary 
Albumin/Creatinine
Uncontrolled DM (n = 42) Controlled DM (n = 20) Non DM (n= 20)
Urinary Type IV Collagen/Creatinine Urinary Type IV Collagen/Creatinine Urinary Type IV Collagen/Creatinine
Table 5. Frequency Analysis of increase of urinary collagen type IV and urinary albumin.
Discussion
Hyperglycemia in patients with DM can lead to microvascular 
and macrovascular complications. This condition can lead 
to increased morbidity and mortality in patients with DM. 
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One of the complications that often occur in individuals 
with DM is the development of DN condition to frank DM 
that will ultimately lead to terminal renal failure or ESRD.
(1,3,4)
 This study was carried out using some biomarkers that 
could be expected to detect the presence of renal impairment 
in patients with DM by observing the role of inflammation 
and the accumulation of ECM. Urinary albumin was used 
to determine the condition of albuminuria (urinary albumin 
≥30 mg/dL).In this study, second morning urine was used 
for measurement of urinary albumin, so that albumin 
excretion reported was in terms of the urinary albumin/
creatinine (µg/mg) ratio. Measurement of urinary GGT 
was used as a marker of cell membranes damage in tubules 
and urinary clusterin used a marker of cells damage in the 
tubulus proximal.(9)
 Hyperglycemic condition will lead to increased non-
enzymatic glycation process which can lead to inflammation 
and increased levels of hs-CRP. Therefore hs-CRP can 
be used to predict the onset of the inflammatory process 
induced by the glycation process on glycemic control in 
poorly controlled DM patients.(15) This study showed no 
significant diferences of the hs-CRP levels between the 
study groups. It was shown that mechanism of albuminuria 
may not occur directly through inflammatory mechanism.
 Type IV collagen is the major constituent of the 
glomerular basement membrane and mesangium matrix. 
Increased glucose levels trigger generation of advanced 
glycation end products (AGEs) that will lead to the 
deposition of type IV collagen in the glomerular mesangial 
matrix due to increased synthesis of type IV collagen, but 
decay decreases, therefore type IV collagen level in the 
blood represents the rate of turnover of the ECM on kidney 
disease.(5)
 HbA1c level in this study was used to assess glycemic 
control in diabetic patients, although with its limitations 
it can only show glycemic control of about 2-3 months 
earlier. This study found that HbA1c levels were positively 
correlated (p <0.05) with urinary type IV collagen/creatinine 
ratio (Table 2). This significant correlation suggests that 
prolonged hyperglycemia condition is characterized by 
increased HbA1c role in the formation of ECM.
 To assess the risk factors for type IV collagen increase 
in uncontrolled DM (HbA1c≥7) compared with controlled 
DM, cross-tabulation analysis was done and showed the 
odds ratio (OR) indicating increase of urinary type IV 
collagen was 9 folds in uncontrolled DM compared with that 
in the control. It means that the risk of ECM accumulation in 
uncontrolled DM was 9 times higher than in the controlled 
DM. It also showed the role of glucose control was essential 
to avoid the accumulation of ECM proteins as one of the 
mechanisms of kidney damage.
 In this study we also found significant differences 
(p<0.05) between urinary type IV collagen/creatinine ratio 
in uncontrolled DM subjects and controlled DM subjects and 
normal subjects, respectively, but no significant difference 
was found between controlled DM subjects with normal 
subjects. This shows the importance of glucose control in 
the prevention of complication development process of the 
disease.
 In the subjects of uncontrolled DM, glucose 
levels were always high that will lead to increase non-
enzymatic glycation process which will produce AGEs, 
and subsequently AGEs will stimulate formation of type IV 
collagen. Excess collagen formation not accompanied with 
swift breakdown causes accumulation of collagen in the 
glomerular basement membrane that leads to changes in the 
structure of the glomerulus.(5)
 The study result is consistent with that of the study 
reported by Sthaneshwar and Chan  who found that 
excretion of type IV collagen was higher in subjects with 
DM compared with that in non-DM subjects.(13)
 Increased urinary albumin in DN is mainly derived 
from the glomerulus. The presence of albumin in the 
urine must be through the glomerular barrier filtration.
(14) Presence of albumin in the urine is a sign of change 
in the glomerular structure due to accumulation of ECM, 
represented by the type IV collagen excretion into the 
urine. Accumulation of ECM causes changes in the size of 
mesangial membrane, increasing intraglomerulus pressure, 
loss of negatively charged glycosaminoglycans on the basal 
membrane of cells and subsequent enlargement of size of 
pores of the filtration membrane causes it to be impermeable 
to albumin, thus resulting in the occurrence of albuminuria.
(14,16)
 This study found that urinary albumin levels in 
uncontrolled DM group were significantly different (p <0.05) 
from those in the controlled DM and normal group, but no 
significant difference (p >0.05) was seen between controlled 
DM and normal subjects. This suggests that diabetic patients 
with good glycemic control may be considered to be in 
similar condition as the subjects who do not suffer from 
DM, therefore it is very important for diabetic patients to 
have their blood glucose levels controlled to prevent kidney 
damage. As reported by Grainer et al., that poor glycemic 
control increases urinary albumin levels significantly in 
patients with DM compared with DM with good glycemic 
control.(17)
 Table 4 showes that the risk factors for the occurrence 
of albuminuria in subjects with high HbA1c levels are 
 167
Renal Damage in Diabetes Mellitus (Sambara Y)Indones  Biomed J.  2013; 5(3): 161-8DOI: 10.18585/inabj.v5i3.66
7.44 times higher (95% CI, 2.243-24.646, p<0.01), and 
increase of  urinary type IV collagen/creatinine to increased 
albuminuria showed 4.27 times greater (95% CI: 1.518-
12.028, p<0.05).
The frequency of albuminuria was found in approximately 
50% of diabetic patients that were accompanied by elevated 
levels of urinary type IV collagen and this did not depend on 
whether the cases are uncontrolled or controlled DM (Table 
5). It can be shown that urinary type IV collagen can also 
be used to assess kidney damage may even be used as a 
predictor of albuminuria in diabetic patients, but to confirm 
it, futher study is needed. 
 The significant correlation between HbA1c levels 
and the urinary type IV collagen/creatinine ratio (p<0.01, 
r=0528), HbA1c and urinary albumin (p=0.019, r=0.213), 
and urinary type IV collagen/creatinine ratio and urinary 
albumin (p=0.000, r=0613) in this study can be concluded 
as a fact that urinary type IV collagen is a promising marker 
in the future that can be used to detect kidney damage 
in patients with type 2 DM. However, to determine its 
sensitivity and specificity, it is necessary to conduct further 
study with more number of samples.
 This study used multiple biomarkers of kidney 
damage that represent different areas of the functional unit 
of the kidney; the urinary albumin representing glomerular 
damage, urinary GGT representing damage to the proximal 
tubular cell membrane and urinary clusterin representing 
damage to the proximal tubular cells. Results of this study 
showed that HbA1c representing control of glucose levels 
in diabetic patients correlated significantly (p<0.05) only 
with urine albumin, whereas both urinary GGT and urinary 
clusterin showed a non-significant correlation (p>0.05). 
This suggests that kidney damage begins at the glomerulus 
in patients with DM before the onset of the damage of the 
cell membrane and proximal tubular cells.
 Significant correlation of HbA1c levels and urinary 
type IV collagen/creatinine ratio with that reported that in 
DM subjects with microalbuminuria there was increase 
of the HbA1c levels.(18) Increased urinary excretion of 
type IV collagen in the subjects with albuminuria was 
also reported by Cohen et al. who found that the increase 
in urinary excretion of type IV collagen is an indicator 
of diabetic kidney disease which has entered the phase 
of compromised filtration function.(12) Ogawa et al. in 
an observational study over a 2-year period also found a 
significant correlation between the increase of urinary 
albumin/creatinine ratio to urinary type IV collagen and that 
in normoalbuminuria subjects, in which type IV collagen 
levels higher evolved into albuminuria within 2 years.(19)
 This study found no correlation between HbA1c 
levels with urinary GGT (Table 3), as well as no significant 
correlation was found between urinary type IV collagen/
creatinine ratio and hs-CRP with urinary GGT. The role of 
GGT in this case was not likely occurs through inflammatory 
mechanisms and accumulation of ECM, to prove which a 
further study is needed.
 The mechanism that involves in urinary GGT in 
kidney damage is still unclear. In the normal subjects, 
urinary enzymes of tubular epithelial cells are excreted 
into the urine in small amounts as a result of the metabolic 
activity of cells. Various conditions are harmful to the cells 
such as hypoxia, anoxia, ischemic and toxic effects of drugs 
followed by a decrease in renal function that will increase 
the number of tubular enzymes in urine. In diabetic patients, 
hyperglycemia can lead to increase in non-enzymatic 
glycation due to changes in energetic status. This will 
damage the cell membrane and cause the release of cells’ 
cytoplasmic organelles into the lumen of the tubules.(20)
 This study found no significant correlation (p>0.05) 
between HbA1c levels and urinary clusterin, also between 
both hs-CRP and urinary type IV collagen/creatinine ratio 
and urinary clusterin. This suggests that the presence 
of chronic inflammation and accumulation of ECM is 
not correlated with urinary clusterin levels. It could be 
argued that the role of clusterin in this case is not possible 
through the mechanism of low-grade inflammation and 
overproduction of ECM. It is concluded therefore that the 
mechanism of clusterin involvement in DN is not clear, on 
which more studies are needed.
Conclusion
This study showed that albumin and type IV collagen 
in urine plays a role in the renal damage caused by 
uncontrolled glucose levels in type 2 DM patients. As one 
of the compilers of the extracellular matrix, urinary type IV 
collagen contributes to the accumulation of ECM, which is 
one mechanism of kidney damage. Increased urinary type 
IV collagen with increased urinary albumin may be a sign 
of glomerular damage. The increase of both HbA1c and 
urinary type IV collagen concentration indicates increase 
of the risk factor for glomerular damage. Urinary type IV 
collagen may be a future potential marker for detection of 
early renal damage.Acknowledgement
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